The subject of tumors of the breast, and particularly the differential diagnosis of these, seems one adequately considered in all texts of surgery and in many monographs; indeed, it is a question to which every medical student is expected to know the answer. Yet I know of no problem in the clinic that is today more worrisome, that requires a better balanced judgment, or for which the solution is more often based upon intangible evidence.
This may not have been true to the same degree in the past when carcinoma of the breast for the most part was seen in the late stages of the disease, presenting the typical text-book picture, and when no woman worried about a "lump" in her breast until it was the size of an orange or had ulcerated, or gave her excruciating pain.
Today, this situation has changed with the education of the public and of the family physician, who have learned that the smallest detectable change from normal in the breast may spell disaster and should be seen by the surgeon at once. Minor discomfort, a drop of secretion, a little excoriation, or a nodule so small that the examiner may be humiliated by being forced to ask the patient to find it for him, are of common occurrence. That this is true is shown in the rising rate of apparent arrests by treatment of carcinoma of the breast, for the lesion is seen more and more frequently at an early stage when radical mastectomy may be done with a considerable chance of benefit. In our own experience8, with no change in treatment-radical surgery-and without radiation of any type, the three-year survivals have risen from 43.5 per cent in the years 1921 to 1925 inclusive to 71.5 per cent in the years 1926 to 1930 inclusive, and the five-year survivals from 31 per cent in the first period to 66 per cent in the second. While this shift may be peculiar to this clinic, I suspect that a similar change accounts for some of the statistics supposed to illustrate the benefits of preoperative and postoperative radiation. Bloodgood2 has more direct evidence as to the frequent appearance of the early lesion, for in an experience in which three decades ago he saw less than 20 per cent of instances in which the lesion was benign, he now sees the situation practically reversed in that only approximately 20 per cent of patients coming to him with a complaint concerning the breast have malignant tumors. While this makes the outlook for the patient much better, it renders the difficulty of diagnosis and the responsibility of the surgeon much greater.
The majority of these patients, not having carcinoma of the breast, are suffering from some variety of that puzzling and illdefined disease of the breast, which has received about as many names as it has had investigators, that is, " chronic cystic mastitis" as it is most commonly called in American literature. It is this condition, which must be differentiated from cancer of the breast, that is to be discussed.
In order better to understand the present situation, it is best to review the development of our knowledge from the historical viewpoint. This disease was first clearly described and differentiated from malignant disease of the breast by Sir Astley Cooper' in his splendid monograph on "The Anatomy and Diseases of the Breast" published in Philadelphia in 1845. This is admirably illustrated with plates showing fibroadenomata and cysts of, the breast, all of which he included under "Hydatid Disease of the Breast." The term had no reference, of course, to the disease which is called hydatid today. From the clinical experience of Velpeau30, Brodie4, Paget2", and Gross12 came confirmation of the benignity of these tumors, although none of these pioneers had adequate facility for microscopic study.
With the development of proper technic for the cutting and staining of tissue, a new period of study occurred. Brissaud5 (1883) gave the first detailed histological description of the disease and influenced Reclus22 in the same year to publish the first modern description. Unfortunately, influenced as have been so many since by the microscopic appearance, they held that the lesion was a malignant one, an opinion that with further clinical experience, however, was revised five years later. They referred to it as "La Maladie Kystique des Mamelles," but it has since become known in the French literature by the eponym of "Maladie de Reclus."
In the German, attention was called to the subject by Schimmelbusch25 (1892) Since then there has been a salting out of opinion as regards the type of reaction into three general schools of thought,-the inflammatory, the neoplastic, and the abnormal involution: The first of these has been largely discarded, partly because the cellular reaction in the stroma first interpreted by K'onig'8 as characteristic of an inflammatory process has, with more accurate cytological knowledge, come to be recognized as not so, and partly because investigators such as Keynes"7 have been uniformly unsuccessful in attempting to demonstrate an infective agent. The neoplastic school, represented today most forcibly by Cheatle7 in surgery, and by many pathologists, is convinced by the histology of that phase of the disease in which the ducts are filled with hyperplastic epithelium and papillomata, that this represents a neoplastic reaction which must lead on to cancer with a fair degree of frequency. In fact, it is diagnosed as cancer in many instances by those of limited experience and possessing a viewpoint confined to the eyepiece of the microscope. Inasmuch as it is acknowledged that the more fibrous and cystic lesions are benign, proponents of this hypothesis are forced into considering "chronic cystic mastitis" as being two diseases, or the whole process at least "precancerous" and therefore neoplastic.
The third school, that holding to the theory of involution, has expanded, with the development of knowledge concerning the functional changes in the breast, into a physiological concept of the disease based upon the response of the organ to hormonal stimulation. This is the most striking recent development and must be considered more in detail. The functional part of the breast is composed of two main components; the ducts and acini lined by epithelium and the periductal and periacinar fibrous tissue, the "Mantelgewebe" as the Germans say. There are then these two types of tissue which are functionally symbiotic and of equal importance.
The growth of the breast pauses shortly after birth, but in the female is taken up again as puberty approaches, probably under the influence of the ovarian follicles which undergo stimulation from. the hormones of the anterior lobe of the hypophysis. Anatomically this growth consists of increase in both the fibrous tissue and the ducts but not in the formation of acini. Overstimulation of this type, as pointed out by Geschickter11, probably leads in the male to gynecomastia, in the female to virginal hypertrophy and, where only certain areas of the breast react, to fibroadenomata. There is then a definite hormonal stimulation of the breast in the female leading to simple growth.
With the rupture of the follicle and the formation of the corpus luteum, the menstrual cycle starts, to be repeated in monthly rhythm until the climacteric or pregnancy supervenes. Exactly what hormones are concerned in this cycle is not yet clear, although Evans"0 lays down certain basic statements. These are to the effect that the estrogenic substance provides for the growth of the breast including the duct system, but not for the development of the secretory acini. The latter, which comprise the functional development of the gland, are dependent upon the lactogenic hormone of the anterior lobe of the pituitary, "prolactin." The estrogenic substance is inhibitory to the "prolactin," and the two are thus in balance, while the secretion of the corpus luteum, "progestin," has no relationship to mammary physiology.
In any case, the anatomical changes in the breast occurring during the estrus cycle are fairly well known. They are based on observations in both man and animals. In 1916 Loeb and Hesselberg'9, working with the guinea pig, found that the mammary glands at the time of heat were actively proliferating with large ducts, some of which were even "cystically dilated" or contained "papilla-like pro-trusions." The epithelium was actively growing with mitoses, changes in shape, and with vesicular nuclei. The stroma was edematous and contained more lymphocytes and polymorphonuclear leukocytes than were found in the resting stage.
In the rat, Sutter27 observed sprout'ing and branching of the duct system during estrus with regression near the next proestrus stage. Similar observations were made in the heifer by Hammond'3, and in the opossum by Hartman"5. In addition, many investigators have observed the experimental activation of the mammary gland by estrogenic substances (Turner28, Wieser32, and Turner and Frank29).
Unfortunately, for the primates there have as yet been published no correspondingly accurate observations. In man the information comes from two methods of attack, one the correlation of the estrus cycle as determined by study of the ovary and the breast, the other by the determination of the estrus by questioning the patient and by the study of breast tissue removed at operation. In the first instance the study is necessarily limited to necropsy material. Such were the initial investigations of Rosenburg24, who demonstrated that the breasts during menstruation underwent marked proliferation of the ductal epithelium and an increase in the cellular content of the periductal fibrous tissue. These observations were confirmed and amplified by Berberich and Jaffe. The second approach has been carried out notably by Moszkowicz20, who was able to correlate in a striking fashion changes in the breast removed at operation with the menstrual cycle. Ingleby"6, in this country, has made similar studies, and there can be no doubt that in the breast of man, as in the lower animals, a rhythmic change in the breast analogous to that in the endometrium takes place in conjunction with and caused by the estrus cycle. On the basis of Ingleby's work Rodman 3 has given a very adequate description of what takes place.
Somewhere between the menstrual cycles the breast is in its resting stage, probably from the fifth to the fifteenth day after the last menses. At this time the fibrous stroma predominates, the epithelial elements are only ducts and occasional acini. In old women and obese young women fat is also present. The ducts are lined by two layers of cells; an inner layer of cuboidal or columnar with nuclei that are small and stain deeply; and the basal cells that are smaller, and tend to be flattened. As the next menstrual period approaches, the cells become larger until they divide and new ductules are formed branching out from the old ducts like twigs on a tree. The epithelial border around the lumen becomes somewhat jagged and irregular, a change similar to that seen in the glands of the premenstrual endometrium. Meanwhile the surrounding fibrous tissue also softens, undergoing myxomatous and hyaline degeneration so as to allow for the expansion of the ducts. Lobules are thus formed which do not appear in the resting breast. The lining epithelial cells swell, the protoplasm becomes vacuolated and the nucleus is rounder and paler. Similar changes take place in the cells of the basal layer. Secretion takes place into the ducts and, clinically, in many women the breasts become swollen and tender at this stage. This then, is the premenstrual phase, and about a day or two before the onset of the menstrual flow, involution begins. At this time the epithelium degenerates and is shed into the lumen of the ducts much the same as the superficial layers of the endometrium are cast off during menstruation. Under the microscope, it is seen that the architecture of the lobules has been lost, and they have a curiously jumbled appearance. One now sees degenerate epithelial cells, often varying in size and shape, intermingled with round cells and proliferating fibrous tissue. After the menses are over these degenerated epithelial cells are absorbed. The breast is now in the postmenstrual phase which is short, as in about five days after the menses the breast again enters the resting stage.
Granted, then, that such a cycle occurs, one may well ask what relationship this has to the disease "chronic cystic mastitis." The final proof rests, of course, upon the reproduction of the phenomenon experimentally, and unfortunately this has not yet been convincingly successful. To obtain the proper hormonal balance and the correct timing is a difficult matter, but the attempts of Geschickter are at least suggestive"1. Certain facts provide, in lieu of this, ancillary evidence. It is not a disease peculiar to man, for it has been described in at least one animal, the mouse (Wieser32). More important is the frequency of occurrence, for if it is present in some degree in a high proportion of females, then it becomes an extraordinarily prevalent disease or, more likely, a very common physiological aberration.
On this there are considerable data. Keynes"7,  
in the Hunterian
Lecture on "chronic mastitis," found in necropsy material involving 116 specimens, 59 showing "inflammatory" lesions. Before the menopause the incidence rose to 60 per cent, so that the phenomenon could not be explained on the basis of involution occurring at or after the menopause. Borchardt and Jaffe3, in a similar study upon women over 40, found some degree of this condition in 93 per cent, and in 70 per cent it was present in both breasts. One may safely conclude that changes of this nature are present so commonly in the female breast that they must represent an aberration of the proliferation and regression that occur at the time of the estrus.
The question is properly raised, however, as to the unity of this disease. May there not be, as Cheatle and Cutler7 suggest, a physiological aberration-"mazoplasia"--and a neoplastic disease-"a desquamative epithelial hyperplasia"-shading into cystadenoma and carcinoma. As a matter of fact, the drawing of a sharp line between these two supposed entities is impossible either histologically or dinically, for the two blend into and over each other in such a fashion that one must consider the picture as that of one entity.
On the other hand, if one looks at the picture as a whole, there is a sharp line of demarcation between carcinoma and "cystic mastitis." In the former the natural history of the disease is that of malignancy, in the latter of benignity. It is true, if one studies the histology of the benign lesion, particularly during the most active phase of physiological hyperplasia, that a picture is often presented in which the impression is gained that the epithelium is about to plunge through the barrier of the membrana propria and establish an invasive focus of cancer. The histologist is loath to take the responsibility of calling such a picture benign; unfortunately, an equivocal answer may be found in terming it "precancerous," in which case he is always right whatever the later course of the disease may disclose. As a matter of fact, as Bloodgood2 has pointed out from a long experience, when the proliferating epithelium is not unquestionably and readily seen to be invasive, the lesion is benign. In other words, real malignancy does not simulate benign disease, whereas many forms of benign disease may suggest histologically the malignant. A detailed technic, although in itself precise, may be misleading in that it gives one too great a confidence in interpretation. The answer can only be found in the study of the natural history of the disease for, after all, the histological picture of malignancy was originally built up on the correlation of microscopic appearance with the progress of the disease.
The fallacies of the determination of the incidence of cancer in "chronic cystic mastitis" as usually presented are twofold. The one is the assumption that the diagnosis of microscopic cancer is valid and the outcome therefore predictable, the other that the sampling of instances of this cystic disease is a fair one and therefore that the incidence of cancer is high. Numerous writers have presented statistics to this effect. The data presented by Semb26 may be taken as an example. He divides the disease we are discussing into two groups, "fibroadenomatosis simplex" (microcystica) and "fibroadeno-matosis cystica," the distinction being that in the latter, the cysts are visible to the naked eye. This last group comprised therefore all those breasts in which a definite localized tumor was palpable. Of these there were 70 cases investigated, in which there were 9 instances of definite fibroadenomata, and 20 of adenomatous papillomata. In 17 instances "infiltrating growth of epithelium" was detected, and of these 10 were diagnosed as "incipient carcinoma," or precancerous lesions, and 7 as fully developed carcinoma. But apparently the total number of breasts investigated was 400, of which 70 then had palpable tumors. Of these, 7, or less than 2 per cent, proved to have definite carcinoma on histologic examination. This is about the incidence of carcinoma in the female breast in general. That these were all found in the palpable group of tumors is of significance, and one may only conclude that in this group there may be, if one is completely incapable of making a differential diagnosis, an error of 10 per cent. The data have no weight in showing that carcinoma originates from "chronic cystic mastitis." Semb argues from the reverse direction also. That is, he, as many others have done, studies the incidence of "fibroadenomatosis" in all instances of cancer of the breast and arrives at the figure of 77 per cent. This is approximately the figure given by Geoffrey Keynes for the incidence of this disease in breasts of corresponding age removed in a run of 100 necropsies, so that there is then no significance in this presumed correlation of chronic cystic mastitis with cancer.
It might be said, however, that Semb was mistaken in his interpretation of what was and what was not carcinoma, and that the "precancerous lesions" should be so classed. This is a valid hypothesis, and the only adequate answer is that which the final outcome may show. There is a great dearth of papers giving the follow-up results in this disease, in spite of the fact that in the final analysis, the decision as to whether or not there is a correlation between "chronic cystic mastitis" and cancer must be made on the basis of such data.
Fortunately, Bloodgood2 has made such a study over many years. First believing that chronic cystic disease was a precancerous lesion, he has arrived by stages at the opposite opinion. In 1921, he reported upon a follow-up of 350 instances of this disease, in which there had been an incidence of carcinoma of about 2 per cent. In 1929 he studied a second group of 100 cases, of an apparently more malignant appearing lesion, the diffuse, non-encapsulated adenoma, and found no development of cancer. In 300 instances of the "bluedomed cyst" in which local excision was practised, there was likewise no subsequent malignancy. In 1931 he reviewed all his "border-line" tumors of the breast and found no subsequent cancer, and in 1934 he goes so far as to state that the comedo-adenoma can be distinguished from the comedo-carcinoma and is a benign lesion.
Campbell6 has admirably reviewed the literature of this disease and determined the subsequent course of 233 patients treated by local excision; of these 9.2 per cent were followed for three or more years, 60.4 per cent for five or more, and 15.9 per cent for ten or wpore. Only one of the 233 patients developed carcinoma and that in a portion of the breast not involved in the excision. Of the 233, 42 were instances of adenocystic disease. Of 57 patients treated by simple amputation, there was one death from carcinoma in which the primary tumor was present in the opposite breast, and a second from what was said to have been carcinoma of the stomach. This is the type of investigation that should show correlation of "chronic cystic mastitis" with carcinoma of the breast if it is present. It is regrettable that more surgeons have not undertaken such a survey. Nevertheless, it seems to me most probable that this disease bears no causal or intimately correlative relationship to cancer of the breast. It is an entity in itself and should be so considered.
On the other hand, one cannot emphasize too strongly the difficulties of a differential diagnosis in a situation where an error may be fatal. In the generalized disease without an individual tumor or definite localization, the chances of error are small, so small indeed that operative attack is unjustifiable. But where there is a definite tumor or a localized area of disease, the error of diagnosis increases to the point where actual examination of the excised tissue must be obtained. This situation has been studied by Hart"4, who has followed up a "border-line" group which is supposedly most malignant in potentiality, that is, the intracystic papillomata. Of 128 cases studied, 104 were benign and 24 malignant, of which 21 were recognized clinically. All of the last group were treated by a radical mastectomy. Of the benign cases 38 per cent had radical amputation, 40 per cent conservative amputations, and 22 per cent local excisions. Sixty-six of these were followed up and all had remained well, while of the malignant group 10 were followed of which seven died of cancer. It seems, then, that about 20 per cent of this so-called "border-line group" are malignant, and that the error of clinical diagnosis is less than 3 per cent for the group as a whole; and about 10 per cent for the malignant component. This is given not as an illustration of the derivation of papillary growth from "chronic cystic disease," but of the greater difficulty of diagnosis where the lesion is a limited one. It is unsafe to depend upon a purely clinical diagnosis in such instances, and excision of the tumor or area in question, often involving a quadrant of the breast, or when the involvement is greater, a conservative total mastectomy, is necessary. It is hardly necessary to add that where the clinical diagnosis of carcinoma is presumptive, the attack should be a radical mastectomy at once.
The differential diagnosis and treatment of tumors of the breast, then, rests upon a concept of the so-called "chronic cystic mastitis" as an aberration of the cyclic changes in that organ associated with estrus, that is to say, it is a benign lesion. In the generalized form diagnosis is safe, but in the types limited to certain areas in the breast or to the single tumor, exploration is necessary because the differential diagnosis from cancer cannot be made with sufficient security.
